ConforMIS Inc. (NASDAQ:CFMS) was up 3% on Friday . The stock traded as high as $8.12 and last traded at $7.94, with a volume of 156,796 shares traded. The stock had previously closed at $7.71.

Several equities research analysts recently weighed in on CFMS shares. JPMorgan Chase & Co. cut ConforMIS from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $18.00 to $8.00 in a research note on Friday, May 13th. Wells Fargo & Co. cut ConforMIS from an “outperform” rating to a “market perform” rating in a research note on Friday, May 13th. Deutsche Bank AG decreased their target price on ConforMIS from $26.00 to $12.00 and set a “buy” rating for the company in a research note on Friday, May 13th. Canaccord Genuity restated a “buy” rating on shares of ConforMIS in a research note on Saturday, May 14th. Finally, Oppenheimer Holdings Inc. started coverage on ConforMIS in a research note on Saturday, May 14th. They set a “buy” rating for the company. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $15.40.

The company has a 50-day moving average of $7.18 and a 200-day moving average of $9.02. The stock’s market cap is $344.56 million.

ConforMIS (NASDAQ:CFMS) last issued its quarterly earnings results on Monday, August 8th. The company reported ($0.34) EPS for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01. The business earned $19.30 million during the quarter, compared to analysts’ expectations of $18.02 million. The company’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the prior year, the company posted ($2.51) EPS. On average, equities research analysts expect that ConforMIS Inc. will post ($1.41) EPS for the current year.

An institutional investor recently raised its position in ConforMIS stock. RS Investment Management Co. LLC boosted its position in ConforMIS Inc. (NASDAQ:CFMS) by 3.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,432,470 shares of the company’s stock after buying an additional 43,490 shares during the period. RS Investment Management Co. LLC owned 3.52% of ConforMIS worth $24,767,000 as of its most recent filing with the SEC.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.